Lido Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14M Buy
34,415
+1,935
+6% +$785K 0.05% 192
2025
Q1
$16.2M Buy
32,480
+8,019
+33% +$3.99M 0.07% 159
2024
Q4
$12.7M Buy
24,461
+2,934
+14% +$1.53M 0.06% 177
2024
Q3
$13.3M Sell
21,527
-543
-2% -$336K 0.07% 154
2024
Q2
$12.2M Buy
22,070
+96
+0.4% +$53.1K 0.07% 145
2024
Q1
$12.8M Sell
21,974
-252
-1% -$147K 0.08% 131
2023
Q4
$11.8M Buy
22,226
+723
+3% +$384K 0.08% 129
2023
Q3
$10.9M Buy
21,503
+479
+2% +$242K 0.08% 123
2023
Q2
$11M Buy
21,024
+1,635
+8% +$853K 0.08% 135
2023
Q1
$11.2M Buy
19,389
+7,779
+67% +$4.48M 0.11% 109
2022
Q4
$6.39M Buy
11,610
+864
+8% +$476K 0.08% 128
2022
Q3
$5.45M Sell
10,746
-1,963
-15% -$995K 0.07% 129
2022
Q2
$6.91M Sell
12,709
-1,765
-12% -$959K 0.09% 99
2022
Q1
$8.55M Buy
14,474
+3,888
+37% +$2.3M 0.1% 97
2021
Q4
$7.06M Buy
10,586
+2,084
+25% +$1.39M 0.08% 119
2021
Q3
$4.86M Buy
8,502
+1,198
+16% +$684K 0.07% 142
2021
Q2
$3.69M Sell
7,304
-1,465
-17% -$740K 0.05% 162
2021
Q1
$4M Buy
8,769
+1,920
+28% +$877K 0.07% 143
2020
Q4
$3.19M Sell
6,849
-1,111
-14% -$518K 0.07% 146
2020
Q3
$3.52M Sell
7,960
-263
-3% -$116K 0.09% 111
2020
Q2
$2.98M Sell
8,223
-1,041
-11% -$377K 0.09% 116
2020
Q1
$2.63M Buy
9,264
+337
+4% +$95.7K 0.11% 102
2019
Q4
$2.9M Buy
8,927
+1,464
+20% +$476K 0.12% 101
2019
Q3
$2.18M Buy
7,463
+265
+4% +$77.2K 0.11% 99
2019
Q2
$2.12M Buy
7,198
+10
+0.1% +$2.94K 0.12% 96
2019
Q1
$1.97M Sell
7,188
-105
-1% -$28.8K 0.13% 97
2018
Q4
$1.63M Buy
7,293
+839
+13% +$188K 0.16% 81
2018
Q3
$1.58M Buy
6,454
+780
+14% +$190K 0.15% 81
2018
Q2
$1.18M Buy
5,674
+720
+15% +$149K 0.14% 90
2018
Q1
$1.02M Buy
4,954
+501
+11% +$103K 0.14% 91
2017
Q4
$845K Buy
4,453
+267
+6% +$50.7K 0.12% 94
2017
Q3
$811K Buy
4,186
+2,310
+123% +$448K 0.13% 91
2017
Q2
$327K Buy
1,876
+239
+15% +$41.7K 0.07% 161
2017
Q1
$279K Buy
1,637
+210
+15% +$35.8K 0.08% 171
2016
Q4
$201K Buy
+1,427
New +$201K 0.05% 194